TriLink BioTechnologies, Inc. (TriLink) today announced that a multi-year distribution and supply agreement has been signed with California-based Affymetrix, Inc., a leading supplier of genetic analysis technologies. Under the terms of agreement, Affymetrix will use TriLink's high quality oligonucleotides in several of their kits.
"TriLink and Affymetrix have a long-standing, strong relationship, and we are thrilled to continue to grow with this great company," commented CEO, Richard Hogrefe.